Fitlife Brands, Inc. (FTLF): Cost of Revenue
$50.01M
Year ended 2025-12-31
$64.27M
Trailing 12 months to 2026-06-30
+43.9%
3-year compound annual growth
+31.8%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $50.01M | +37.4% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $36.39M | +16.4% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $31.27M | +86.5% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $16.77M | +8.8% | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | $15.41M | +22.5% | 2023-03-24, From 2021-01-01 |
| 2020-12-31 | $12.57M | +12.7% | 2022-10-13, From 2020-01-01 |
| 2019-12-31 | $11.15M | n/a | 2022-10-13, From 2019-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Fitlife Brands, Inc. (FTLF) | 2025-12-31 | $50.01M | +37.4% |
| Mannatech Inc (MTEX) | 2025-12-31 | $27.08M | +2.5% |
| Niagen Bioscience, Inc. (NAGE) | 2025-12-31 | $46.23M | +21.6% |
| Natural Alternatives International Inc (NAII) | 2026-06-30 | $133.52M | +10.7% |
| Marimed Inc. (MRMD) | 2025-12-31 | $101.94M | +7.2% |
| Glass House Brands Inc. (GLAS) | 2025-12-31 | $105.02M | +1.5% |
| Leef Brands Inc. (LEEEF) | 2025-12-31 | $24.30M | +16.8% |
| C21 Investments Inc. (CWLXF) | 2026-03-31 | $19.01M | +8.3% |
| Synergy CHC Corp. (SNYRQ) | 2025-12-31 | $10.08M | -9.9% |
Compare FTLF, MTEX, NAGE, NAII side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗